Erratum to: Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer
Britten, Carolyn D., Adjei, Alex A., Millham, Robert, Houk, Brett E., Borzillo, Gary, Pierce, Kristen, Wainberg, Zev A., LoRusso, Patricia M.Volume:
32
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-014-0069-6
Date:
June, 2014
File:
PDF, 67 KB
english, 2014